Sachin S. Gaikwad

Mr. Sachin S. Gaikwad


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SGSachin S. Gaikwad
Sachin S. Gaikwad
AZAbhijit L. Zanje
Abhijit L. Zanje
JSJeevan D. Somwanshi
Jeevan D. Somwanshi

24 May 2023 in Heliyon
Verified
Journal Article
Open access
SGSachin S. Gaikwad
Sachin S. Gaikwad
YMYogita Y. Morade
Yogita Y. Morade
AKAkshada M. Kothule
Akshada M. Kothule
SKSanjay J. Kshirsagar
Sanjay J. Kshirsagar
ULUmesh D. Laddha
Umesh D. Laddha
KSKishor S. Salunkhe
Kishor S. Salunkhe
One of the major causes of death on the globe is cancer. It has remained a significant obstacle for current therapies and has not yet been effectively treated. Conventional treatment strategies available for cancer such as surgery, chemotherapy, radiation therapy etc. have severe adverse effects. The use of herbal active constituents in cancer treatment has tremendous potential to increase the effectiveness of conventional cancer therapy. Natural plant active components have been reported to have strong in vitro pharmacological activity but narrow in vivo absorption. In order to increase their bioavailability and absorption and get around the drawbacks and negative effects of traditional herbal extracts, Phytosomes are one of the growing nanotechnologies that can be used to improve the miscibility of bioactive phytoconstituents in lipid-rich barriers and overcome their poor bioavailability. Many novel drug delivery carriers are employed for targeted delivery of phytoconstituent at the site of action. Phytosomes are well-known biocompatible nanocarriers that can be employed to increase the solubility and permeability of phytopharmaceuticals among various novel drug delivery systems (NDDS). This review mainly focused on various conventional as well as novel approaches and various Nano carrier used in cancer therapies. Also comprising summary of the most recent research on the development and use of phytosomes as a better carrier for herbal constituents in the treatment of cancer. Additionally provides information about the formulation, characterization technique and mechanism of drug release from phytosome. Some of the major herbal active constituents made of phytosome which have shown proven anticancer activity are also studied. Finally, challenges and future perspective related to phytosome in cancer treatment are also discussed.

2 January 2020 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
SGSachin S. Gaikwad
Sachin S. Gaikwad
SKSanjay J. Kshirsagar
Sanjay J. Kshirsagar
Background: Among all available dosage form, tablet is most widely used because of its stability and patient acceptability. The better aesthetic quality like color, texture, mouth feel, and taste masking depended on film and sugar coatings, so the coating is an important part in the formulation of the tablet. The present work aims to comprehensively review the formulation, characterization, and challenges in the development of Tablet in Tablet dosage form. Main text: Film and sugar coatings have the number of disadvantages; most important one is the utilization of aqueous or organic solvent that leads to toxicity. To overcome this problem in the year 1896, Noyes firstly introduced the compression coating or Tablet in Tablet technique. In the development of Tablet in Tablet dosage form, substantial attention among researchers and various research reports and patents inputs can be found in the literature. Also, we focused on the recent advancements in techniques like one-step dry-coating (OSDrC®) for manufacturing Tablet in Tablet dosage form. Conclusion: The current review gathered information on the latest patent, formulation, advantages, and disadvantages of Tablet in Tablet or compression coating. The review also elaborates on the importance of Tablet in Tablet techniques in the development of a modified release system. Graphical

9 February 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
SGSachin S. Gaikwad
Sachin S. Gaikwad
SPSnehal R. Pathare
Snehal R. Pathare
MMMayur A. More
Mayur A. More
NWNikita A. Waykhinde
Nikita A. Waykhinde
ULUmesh D. Laddha
Umesh D. Laddha
KRKuldeep H. Ramteke
Kuldeep H. Ramteke

28 April 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SGSachin S. Gaikwad
Sachin S. Gaikwad
JMJavier O. Morales
Javier O. Morales
NLNarayan B. Lande
Narayan B. Lande
JCJohanna Catalán-Figueroa
Johanna Catalán-Figueroa
ULUmesh D. Laddha
Umesh D. Laddha
SKSanjay J. Kshirsagar
Sanjay J. Kshirsagar

8 February 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SGSachin S. Gaikwad
Sachin S. Gaikwad
AKAkshada M. Kothule
Akshada M. Kothule
YMYogita Y. Morade
Yogita Y. Morade
SPSakshi S. Patil
Sakshi S. Patil
ULUmesh D. Laddha
Umesh D. Laddha
KSKishor S. Salunkhe
Kishor S. Salunkhe